Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

US Patent 8119599 · Granted Feb 21, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Shield for spinal defect2025
Crosslinker enhanced repair of connective tissues2021
Crosslinker enhanced repair of connective tissues2019
Tissue crosslinking for treatment of snoring and obstructive sleep apnea2018
Crosslinker enhanced repair of knee meniscus2016
Tissue crosslinking for treatment of snoring and obstructive sleep apnea2015
Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce 2015
Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce 2015
Non-toxic crosslinking reagents to resist curve progression in scoliosis and inc2013
Formulations for nonsurgical exogenous crosslink therapy2012
Formulations for nonsurgical exogenous crosslink therapy2012
Direct application of non-toxic crosslinking reagents to resist progressive spin2012